Literature DB >> 17133338

Restituting intestinal epithelial cells exhibit increased transducibility by adenoviral vectors.

Filippos Kesisoglou1, Phyllissa Schmiedlin-Ren, David Fleisher, Blake Roessler, Ellen M Zimmermann.   

Abstract

BACKGROUND AND AIMS: While mature enterocytes are resistant to transduction by adenovirus type 5 (Ad5) vectors, undifferentiated cells are transduced much more efficiently. Our purpose was to study enterocyte transduction in models of intestinal wound healing.
METHODS: Transduction was studied ex vivo using cultures of endoscopic biopsies and in vitro utilizing Caco-2 cells in models of mucosal wound healing. Vectors carried either the LacZ or the luciferase gene. CAR (coxsackievirus and adenovirus receptor) and integrins were studied with transduction inhibition and immunofluorescent staining.
RESULTS: Increased transduction efficiency was observed for a subset of enterocytes with a flattened de-differentiated phenotype present at the edge of cultured biopsies. In the in vitro systems, expanding Caco-2 cell monolayers exhibited increased transducibility that was time- and dose-dependent, reaching virtually 100% in cells along the leading edge at high viral load. Bioluminescence activity of transduced expanding monolayers was up to 3-fold greater than that of non-expanding monolayers ('fence' system, 48 h, MOI 1000, p < 0.05). Mitomycin C pre-treatment did not affect levels of transduction in expanding monolayers. At the highest viral load tested, CAR or integrin blocking prior to virus application resulted in 39.4% and 45.4% reduction in transduction levels (p < 0.05). Immunofluorescence revealed altered expression of CAR on the migrating edge of the Caco-2 cultures and the expression of CAR on the apical membrane of biopsy enterocytes.
CONCLUSIONS: Increased CAR and integrin accessibility in migrating enterocytes mediates increased transduction by Ad5 vectors. This subset of enterocytes provides a target for the delivery of genes of interest for both research and gene therapy applications. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 17133338     DOI: 10.1002/jgm.981

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  6 in total

1.  Adenoviral transduction of enterocytes and M-cells using in vitro models based on Caco-2 cells: the coxsackievirus and adenovirus receptor (CAR) mediates both apical and basolateral transduction.

Authors:  Filippos Kesisoglou; Phyllissa Schmiedlin-Ren; David Fleisher; Ellen M Zimmermann
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

2.  Human colon tissue in organ culture: calcium and multi-mineral-induced mucosal differentiation.

Authors:  Michael K Dame; Indiradevi Veerapaneni; Narasimharao Bhagavathula; Madhav Naik; James Varani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-11-20       Impact factor: 2.416

3.  Effective in vivo and ex vivo gene transfer to intestinal mucosa by VSV-G-pseudotyped lentiviral vectors.

Authors:  Hiroshi Matsumoto; Takahiro Kimura; Kazunori Haga; Noriyuki Kasahara; Peter Anton; Ian McGowan
Journal:  BMC Gastroenterol       Date:  2010-05-11       Impact factor: 3.067

4.  Development and evaluation of a porcine in vitro colon organ culture technique.

Authors:  Matheus O Costa; John C S Harding; Janet E Hill
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-06-23       Impact factor: 2.416

5.  Human colon tissue in organ culture: preservation of normal and neoplastic characteristics.

Authors:  Michael K Dame; Narasimharao Bhagavathula; Cohra Mankey; Marissa DaSilva; Tejaswi Paruchuri; Muhammad Nadeem Aslam; James Varani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02       Impact factor: 2.416

Review 6.  Targeting the gastrointestinal tract with viral vectors: state of the art and possible applications in research and therapy.

Authors:  Roeland Buckinx; Jean-Pierre Timmermans
Journal:  Histochem Cell Biol       Date:  2016-09-24       Impact factor: 2.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.